ANASTROZOLE

Anatrozol

Get in touch with us!












      I accept conditions of use and privacy policy of this website.

    I want to receive updated information on the latest news.

    An overview

    Anastrozole is a hormone therapy drug used to treat breast cancer in women who have gone through menopause.


    Anastrozole is used after surgery and other treatments to reduce the risk of breast cancer returning. It is usually taken for a few years. It is also used to control breast cancer that has spread to other parts of the body (secondary breast cancer).

    • Product Type: Oncological. Enzyme inhibitor
    • CAS Number: 120511-73-1
    • Common Indications: Breast cancer treatment
    • Product Status: Commercial
    • Available Grades: Non-Micronized
    • Documentation: CEP, US DMF and Japanese DMF,  ASMF in CTD format, CoA, MSDS
    Anastrozole

    Advantages

    Efficacy:

    • More effective than Tamoxifen for early BC stage.

    • Strongly recommended by NICE in all stages BC.

    Safety:

    • Low toxicity.

    • FDA and EMA approved to treat Breast Cancer (BC).

    Finished
    Dosage Forms

    Coated tablets:

    1 mg

    Global market status

    0 M

    global market sales in 2023 

    0 MT

    consumed globally

    0 %

    Lorem ipsum solor

    Few API manufacturers to cover worldwide demand.

    Our API

    Anastrozol

    • Our API Anastrozol is manufactured in accordance with cGMP and stringent international quality standards. 

    Quality

    • Our quality control follows every stage from development of analytical methods to the control of manufacturing process.

    Samples availables

    destacado
    MINOCYCLINE

    PATENT PROTECTION

    Logo OFF

    Contact us & obtain the technical sheet












        I accept conditions of use and privacy policy of this website.

      I want to receive updated information on the latest news.

      Suanfarma